bioLytical Laboratories Inc. Announces Health Canada Authorization of its rapid INSTI® HCV Antibody Test for Professional Use in Canada
04 nov. 2024 12h00 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Canadian market
bioLytical Announces Final Results of Substantial Issuer Bid
23 août 2024 14h56 HE
|
bioLytical Laboratories Inc.
VANCOUVER, British Columbia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. (the “Company” or “bioLytical”) announces that it has taken up and paid for 18,234,667 common shares (the...
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27 juin 2024 09h00 HE
|
bioLytical Laboratories Inc.
bioLytical helps boost testing with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support national testing efforts
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
19 mai 2024 18h00 HE
|
bioLytical Laboratories Inc.
bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)
bioLytical Laboratories Inc. fait des dons de tests de dépistage pour aider à accroître l'accès international au dépistage en prévision de la Semaine internationale du dépistage
22 nov. 2023 17h10 HE
|
bioLytical Laboratories Inc.
bioLytical, en partenariat avec l'ONG Coalition Plus, a fait don de plus de 8 000 tests rapides de dépistage dans les 25 pays et organisations partenairesbioLytical est une société canadienne qui...
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
22 nov. 2023 13h30 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. and NGO Coalition Plus Lead the Charge to Promote the Importance of Rapid Testing during International Testing Week
bioLytical Laboratories Inc. obtiene autorización de Health Canada para su prueba de anticuerpos INSTI® Multiplex VIH-1/2 y Sífilis
27 mars 2023 09h07 HE
|
bioLytical Laboratories Inc.
bioLytical obtuvo autorización de Health Canada para la venta de su prueba de anticuerpos INSTI® Multiplex VIH-1/2 y Sífilis en Canadá para uso profesional en escenarios de punto de atención médica.Al...
bioLytical Laboratories Inc.的INSTI®多重HIV-1/2梅毒抗体检测试剂盒获得加拿大卫生部授权
27 mars 2023 09h07 HE
|
bioLytical Laboratories Inc.
bioLytical获加拿大卫生部授权在加拿大销售INSTI®多重HIV-1/2梅毒抗体检测试剂盒，供专业医护场所使用该检测使用一个样本即可提供两种感染结果，可让医疗保健专业人员在更短的时间内检测更多的人，从而有助减轻患者的测试焦虑该试剂盒采用便携设计，可在多种场景中进行检测，而且检测结果易于理解作为加拿大卫生部审查和授权流程的一部分，此次提交材料中包括历时两年的PoSH研究临床数据。该项研究由阿...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
27 mars 2023 08h00 HE
|
bioLytical Laboratories Inc.
bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settingsBy providing results for two...
bioLytical Laboratories Inc. obtiene PQ de la OMS para su prueba casera de antígeno iStatis COVID-19
18 oct. 2022 15h02 HE
|
bioLytical Laboratories Inc.
De los fabricantes de INSTI®, bioLytical lanza una nueva plataforma, iStatis, creada para garantizar que todas las personas del mundo tengan acceso a pruebas confiablesbioLytical obtiene elegibilidad...